Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON)

International Journal of Cancer

Volumn 120, Issue 4, 2007, Pages 868-874

  Van Iersel, Carola A ^a   De Koning, Harry J ^a   Draisma, Gerrit ^a   Mali, Willem P T M ^b   Scholten, Ernst Th ^c   Nackaerts, Kristiaan ^d   Prokop, Mathias ^b   Habbema, J Dik F ^a   Oudkerk, Mathijs ^e   Van Klaveren, Rob J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Kennemer Gasthuis Haarlem ^*  (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Computed tomography; Lung cancer; Power; Risk estimation; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION RISK; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SMOKING CESSATION;

AGED; BELGIUM; CLINICAL PROTOCOLS; CONTROL GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PATIENT SELECTION; RISK FACTORS; SAMPLE SIZE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846564385     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22134     Document Type: Article

References (37)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press, 2004.
2. Janssen-Heijnen ML, Coebergh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 2001;31:123-37.
3. Kaneko M, Eguchi K, Ohmatsu H, Kakinuma R, Naruke T, Suemasu K, Moriyama N. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802.
4. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
5. Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. N Engl J Med 2005;352:2714-20.
6. International Prostate Screening Trial Evaluation Group. Rationale for randomised trials of prostate cancer screening. Eur J Cancer 1999;35:262-71.
7. Board of Scientific Advisors, National Cancer Institute. Meeting Minutes, Bethesda, MD, March 7-8, 2005. Available at: http://deainfo. nci.nih.gov/advisory/bsa/bsa0305/07mar05mins.htm.
8. Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, Hasegawa M, Kawakami S, Kubo K, Haniuda M, Yamanda T. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001;84:25-32.
9. Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002;122:15-20.
10. Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, Kakinuma R, Ohmatsu H, Nagai K, Nishiyama H, Matsui E, Eguchi K. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002;20:911-20.
11. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby D, Pasmantier M, Koizumi J, Altorki N, Smith JP. Early Lung Cancer Action Project: a summary of the findings on baseline screening. Oncologist 2001;6;147-52.
12. Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, Heindel W. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002;222:773-81.
13. Diederich S, Thomas M, Semik M, Lenzen H, Roos N, Weber A, Heindel W, Wormanns D. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol 2004;14:691-702.
14. Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS, Clayton AC et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508-13.
15. Pastorino U, Bellomi M, Landoni C, De Fiori E, Arnaldi P, Picchio M, Pelosi G, Boyle P, Fazio F. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362:593-7.
16. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-21.
17. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005;47:9-15.
18. National Cancer Institute, Division of Cancer Prevention. NCI cancer Data Standards Registry (caDSR). Version 3.0.1.2, Build 20. Available at: http://cdebrowser.nci.nih.gov/CDEBrowser/.
19. National Institutes of Health, Behavior Change Consortium. Recommended smoking measures. Available at: http://www1.od.nih.gov/behaviorchange/measures/ smoking.htm.
20. Pistelli F, Viegi G, Carrozzi L, Ronmark E, Lundback B, Giuntini C. Appendix 3: compendium of respiratory standard questionnaires for adults (CORSQ). Eur Respir Rev 2001;11:118-43.
21. Thun MJ, Meyers DG, Day-Lally C, Namboodiri MM, Calle EE, Flanders WD, Adams SL, Heath CWJ. Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II. In: Burns DM, Garfinkel L, Samet J, eds. Changes in cigarette-related risks and their implications for prevention and control (Smoking and tobacco control monograph No. 8). Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institute of Health, National Cancer Institute, 1997. Chapter 5, 383-475.
22. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 1993;85:457-64.
23. Burns DM, Shanks TG, Choi W, Thun MJ, Heath CWJ, Garfinkel L. The American Cancer Society Cancer Prevention Study I: 12-year follow up of 1 million men and women. In: Burns DM, Garfinkel L, Samet J, eds. Changes in cigarette-related risks and their implications for prevention and control (Smoking and tobacco control monograph No. 8). Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institute of Health, National Cancer Institute, 1997. Chapter 3, 113-304.
24. Gohagan JK, Prorok PC, Kramer BS, Cornell JE. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. J Urol 1994;152:1905-9.
25. de Koning HJ, Liem MK, Baan CA, Boer R, Schroder FH, Alexander FE. Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial. Int J Cancer 2002;98:268-73.
26. Otto SJ, Schroder FH, de Koning HJ. Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias? J Med Screen 2004;11:89-92.
27. Statistics Netherlands. Self-reported health and lifestyle, smoking. 2003 Statline. Available at: http://statline.cbs.nl/StatWeb.
28. Bain C, Feskanich D, Speizer FE, Thun M, Hertzmark E, Rosner BA, Colditz GA. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004;96:826-34.
29. Visbal AL, Williams BA, Nichols FC, III, Marks RS, Jett JR, Aubry MC, Edell ES, Wampfler JA, Molina JR, Yang P. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004;78:209-215; discussion 15.
30. Dutch Institute for Healthcare and Association of Comprehensive Cancer Centres. Guideline non-small cell lung carcinoma: staging and treatment. Alphen aan den Rijn, The Netherlands: Van Zuiden Communications BV, 2004. 180 p.
31. Bach PB, Elkin EB, Pastorino U, Kattan MW, Mushlin AI, Begg CB, Parkin DM. Benchmarking lung cancer mortality rates in current and former smokers. Chest 2004;126:1742-9.
32. Friedman GD, Tekawa I, Sadler M, Sidney S. Smoking and mortality: the Kaiser permanente experience. In: Burns DM, Garfinkel L, Samet J, eds. Changes in cigarette-related risks and their implications for prevention and control (Smoking and tobacco control monograph No. 8). Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institute of Health, National Cancer Institute, 1997. Chapter 6, 477-99.
33. Hrubec Z, McLaughlin JK. Former cigarette smoking and mortality among U.S. veterans: a 26-year followup, 1954-1980. In: Burns DM, Garfinkel L, Samet J, eds. Changes in cigarette-related risks and their implications for prevention and control (Smoking and tobacco control monograph No. 8). Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institute of Health, National Cancer Institute, 1997. Chapter 7, 501-30.
34. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519.
35. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, Hsieh LJ, Begg CB. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8.
36. Flanders WD, Lally CA, Zhu BP, Henley SJ, Thun MJ. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res 2003;63:6556-62.
37. Hazelton WD, Clements MS, Moolgavkar SH. Multistage carcinogenesis and lung cancer mortality in three cohorts. Cancer Epidemiol Biomarkers Prev 2005;14:1171-81.